Related Experiment Videos
Using regulatory APCs to induce/maintain tolerance
Amy E Juedes1, Matthias G Von Herrath
1Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA.
Annals of the New York Academy of Sciences
|December 18, 2003
Summary
Antigen-presenting cells (APCs), like dendritic cells (DCs), can both stimulate and suppress immune responses. This review explores their dual regulatory roles in immunity and autoimmunity.
Area of Science:
- Immunology
- Cell Biology
Background:
- Antigen-presenting cells (APCs), particularly dendritic cells (DCs), are crucial for initiating immune responses.
- APCs are recognized as key drivers of immune, autoimmune, and host-defense mechanisms.
- Emerging evidence indicates that APCs also possess significant immune-regulatory (off) capabilities.
Purpose of the Study:
- To review and summarize the evidence supporting the regulatory functions of APCs.
- To explore whether regulatory APC functions represent a distinct lineage or are acquired during maturation.
- To highlight the importance of species (human vs. mouse) and origin (spleen, lymph node, blood) differences in APC function.
Main Methods:
- Literature review of existing studies on APC function.
- Analysis of evidence for both immune-stimulatory and immune-suppressive roles of APCs.
- Comparative analysis of APCs from different sources and species.
Main Results:
- APCs exhibit potent immune-stimulatory functions, driving adaptive immunity.
- APCs also demonstrate regulatory functions, capable of suppressing immune responses.
- Understanding these dual roles is critical, with variations observed between human and mouse DCs, and APCs derived from different tissues.
Conclusions:
- APCs possess a dual capacity to both activate and regulate immune responses.
- Further research is needed to elucidate the mechanisms and lineage of regulatory APCs.
- A comprehensive understanding of APCs' positive and negative roles will advance APC-based therapies for infectious diseases, cancer, and autoimmune disorders.